404 related articles for article (PubMed ID: 24310267)
1. Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome.
Jalanka-Tuovinen J; Salojärvi J; Salonen A; Immonen O; Garsed K; Kelly FM; Zaitoun A; Palva A; Spiller RC; de Vos WM
Gut; 2014 Nov; 63(11):1737-45. PubMed ID: 24310267
[TBL] [Abstract][Full Text] [Related]
2. Altered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress.
Sundin J; Rangel I; Fuentes S; Heikamp-de Jong I; Hultgren-Hörnquist E; de Vos WM; Brummer RJ
Aliment Pharmacol Ther; 2015 Feb; 41(4):342-51. PubMed ID: 25521822
[TBL] [Abstract][Full Text] [Related]
3. The relationship between faecal-associated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects.
Rangel I; Sundin J; Fuentes S; Repsilber D; de Vos WM; Brummer RJ
Aliment Pharmacol Ther; 2015 Nov; 42(10):1211-21. PubMed ID: 26376728
[TBL] [Abstract][Full Text] [Related]
4. IBS with intestinal microbial dysbiosis: a new and clinically relevant subgroup?
Simrén M
Gut; 2014 Nov; 63(11):1685-6. PubMed ID: 24569059
[No Abstract] [Full Text] [Related]
5. Microbial signatures in post-infectious irritable bowel syndrome--toward patient stratification for improved diagnostics and treatment.
Jalanka J; Salonen A; Fuentes S; de Vos WM
Gut Microbes; 2015; 6(6):364-9. PubMed ID: 26512631
[TBL] [Abstract][Full Text] [Related]
6. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota.
Jeffery IB; O'Toole PW; Öhman L; Claesson MJ; Deane J; Quigley EM; Simrén M
Gut; 2012 Jul; 61(7):997-1006. PubMed ID: 22180058
[TBL] [Abstract][Full Text] [Related]
7. A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome.
Ahluwalia B; Iribarren C; Magnusson MK; Sundin J; Clevers E; Savolainen O; Ross AB; Törnblom H; Simrén M; Öhman L
Cells; 2021 Jun; 10(6):. PubMed ID: 34200772
[TBL] [Abstract][Full Text] [Related]
8. Serine proteases as luminal mediators of intestinal barrier dysfunction and symptom severity in IBS.
Edogawa S; Edwinson AL; Peters SA; Chikkamenahalli LL; Sundt W; Graves S; Gurunathan SV; Breen-Lyles M; Johnson S; Dyer R; Graham R; Chen J; Kashyap P; Farrugia G; Grover M
Gut; 2020 Jan; 69(1):62-73. PubMed ID: 30923071
[TBL] [Abstract][Full Text] [Related]
9. Comparison of faecal microbiota in Blastocystis-positive and Blastocystis-negative irritable bowel syndrome patients.
Nagel R; Traub RJ; Allcock RJ; Kwan MM; Bielefeldt-Ohmann H
Microbiome; 2016 Aug; 4(1):47. PubMed ID: 27580855
[TBL] [Abstract][Full Text] [Related]
10. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers.
Krogius-Kurikka L; Lyra A; Malinen E; Aarnikunnas J; Tuimala J; Paulin L; Mäkivuokko H; Kajander K; Palva A
BMC Gastroenterol; 2009 Dec; 9():95. PubMed ID: 20015409
[TBL] [Abstract][Full Text] [Related]
11. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification.
Lyra A; Rinttilä T; Nikkilä J; Krogius-Kurikka L; Kajander K; Malinen E; Mättö J; Mäkelä L; Palva A
World J Gastroenterol; 2009 Dec; 15(47):5936-45. PubMed ID: 20014457
[TBL] [Abstract][Full Text] [Related]
12. Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome.
Yang M; Zhang L; Hong G; Li Y; Li G; Qian W; Xiong H; Bai T; Song J; Hou X
J Gastroenterol Hepatol; 2020 May; 35(5):795-805. PubMed ID: 31674052
[TBL] [Abstract][Full Text] [Related]
13. Differences of microbiota in small bowel and faeces between irritable bowel syndrome patients and healthy subjects.
Chung CS; Chang PF; Liao CH; Lee TH; Chen Y; Lee YC; Wu MS; Wang HP; Ni YH
Scand J Gastroenterol; 2016; 51(4):410-9. PubMed ID: 26595305
[TBL] [Abstract][Full Text] [Related]
14. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.
Kaiser T; Langhorst J; Wittkowski H; Becker K; Friedrich AW; Rueffer A; Dobos GJ; Roth J; Foell D
Gut; 2007 Dec; 56(12):1706-13. PubMed ID: 17675327
[TBL] [Abstract][Full Text] [Related]
15. Instability of the faecal microbiota in diarrhoea-predominant irritable bowel syndrome.
Durbán A; Abellán JJ; Jiménez-Hernández N; Artacho A; Garrigues V; Ortiz V; Ponce J; Latorre A; Moya A
FEMS Microbiol Ecol; 2013 Dec; 86(3):581-9. PubMed ID: 23889283
[TBL] [Abstract][Full Text] [Related]
16. Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome.
El-Salhy M; Casen C; Valeur J; Hausken T; Hatlebakk JG
World J Gastroenterol; 2021 May; 27(18):2219-2237. PubMed ID: 34025075
[TBL] [Abstract][Full Text] [Related]
17. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study.
Halkjær SI; Christensen AH; Lo BZS; Browne PD; Günther S; Hansen LH; Petersen AM
Gut; 2018 Dec; 67(12):2107-2115. PubMed ID: 29980607
[TBL] [Abstract][Full Text] [Related]
18. Association between
Jabbar KS; Dolan B; Eklund L; Wising C; Ermund A; Johansson Å; Törnblom H; Simren M; Hansson GC
Gut; 2021 Jun; 70(6):1117-1129. PubMed ID: 33177165
[TBL] [Abstract][Full Text] [Related]
19. Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD.
Casén C; Vebø HC; Sekelja M; Hegge FT; Karlsson MK; Ciemniejewska E; Dzankovic S; Frøyland C; Nestestog R; Engstrand L; Munkholm P; Nielsen OH; Rogler G; Simrén M; Öhman L; Vatn MH; Rudi K
Aliment Pharmacol Ther; 2015 Jul; 42(1):71-83. PubMed ID: 25973666
[TBL] [Abstract][Full Text] [Related]
20. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome.
Rajilić-Stojanović M; Biagi E; Heilig HG; Kajander K; Kekkonen RA; Tims S; de Vos WM
Gastroenterology; 2011 Nov; 141(5):1792-801. PubMed ID: 21820992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
